Aryoung J. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Malignant epithelial states drive immune dysfunction in ampulla of Vater carcinoma.

Malignant epithelial states drive immune dysfunction in ampulla of Vater carcinoma.

Journal: Biomarker research

Published: March 30, 2026

Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease.

Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: The journal of nutrition, health & aging

Published: January 18, 2026

Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.

Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.

Journal: Diagnostic and interventional imaging

Published: July 16, 2025

Incidence of Chronic Kidney Disease According to Steatotic Liver Disease and Its Subclassifications: A Longitudinal Cohort Study.

Incidence of Chronic Kidney Disease According to Steatotic Liver Disease and Its Subclassifications: A Longitudinal Cohort Study.

Journal: Gut and liver

Published: April 03, 2025

Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type.

Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type.

Journal: Journal of gastroenterology and hepatology

Published: July 09, 2024

Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma.

Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma.

Journal: Gut and liver

Published: May 12, 2024

New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study.

New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 30, 2024

Massive Transfusion Protocol and Outcome of Patients with Acute Variceal Bleeding.

Massive Transfusion Protocol and Outcome of Patients with Acute Variceal Bleeding.

Journal: Journal of clinical medicine

Published: March 10, 2024

Risk factors and management of iatrogenic colorectal perforation in diagnostic colonoscopy: a single-center cohort study.

Risk factors and management of iatrogenic colorectal perforation in diagnostic colonoscopy: a single-center cohort study.

Journal: Scandinavian journal of gastroenterology

Published: February 21, 2024

Clinicopathologic and Endosonographic Characteristics of Colon Subepithelial Tumors Discovered Incidentally.

Clinicopathologic and Endosonographic Characteristics of Colon Subepithelial Tumors Discovered Incidentally.

Journal: Diagnostics (Basel, Switzerland)

Published: January 07, 2024

Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score.

Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score.

Journal: PloS one

Published: November 22, 2023

Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification.

Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification.

Journal: Liver cancer

Published: October 12, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026